SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
Status:
Recruiting
Trial end date:
2024-01-04
Target enrollment:
Participant gender:
Summary
The study looks at how liraglutide works on participant's body weight. Researchers will look
at how liraglutide can help children with obesity to lose weight. They will look at how much
weight the children will lose, and if there are any side effects.
Participants will either get liraglutide or placebo. Which treatment the participants get is
decided by chance. Liraglutide is a new medicine for children, but it can already be
prescribed by doctors to adults with overweight or obesity. The participant will get 1
injection every day.
In addition to taking the medicine, the participants will have talks with the study staff
about healthy food choices, how they can be more physically active and what can be done to
help the participants to lose weight.
The study will last for about 96 weeks (almost 2 years). The participants will have 18 clinic
visits and 10 phone or video calls with the study doctor/staff. Participant will have blood
samples taken, have 1 test to check the heart, 1 hand X-ray taken and must fill in a diary
between some of the visits.